Clinical Trial Update: A Study of MK-6913 for the Treatment of Hot Flashes in Postmenopausal Women (6913-004) [Phase 2]

View source ↗

Summary

Phase 2 trial of MK-6913 for hot flashes in postmenopausal women was terminated; results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause Vasomotor Symptoms
• Postmenopausal Hot Flashes

Drugs mentioned

• MK-6913 (MK-6913)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Moderate to Severe Vasomotor Symptoms in Postmenopausal, Women | Phase 2 | Status: TERMINATED | Results posted: 2016-05-04